Gregory Gregoriadis
Presidente en The International Liposome Society .
Cargos activos de Gregory Gregoriadis
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| The International Liposome Society | Presidente | 01/01/2003 | - |
Historial de carrera de Gregory Gregoriadis
Antiguos cargos conocidos de Gregory Gregoriadis.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Director/Miembro de la Junta | 13/10/2009 | 10/02/2014 |
| Director Técnico/Científico/I+D | 01/01/1997 | 10/02/2014 | |
| Fundador | 13/10/2009 | 10/02/2014 | |
| University of London | Corporate Officer/Principal | - | - |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Corporate Officer/Principal | 17/11/2010 | - |
Formación de Gregory Gregoriadis.
| University of London | Doctorate Degree |
Estadísticas
Internacional
| Reino Unido | 4 |
| Canadá | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Commercial Services | 3 |
| Health Technology | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
| The International Liposome Society | Commercial Services |
- Bolsa de valores
- Insiders
- Gregory Gregoriadis
- Experiencia
